Cannabis Use History Changed Oral THC Ratings Differently at Lower and Higher Doses

Frequent users did not simply report weaker oral THC effects at every dose in a small human study. The direction of the difference depended on dose, illustrating why use history cannot be summarized by one uniform tolerance factor.

The groups were defined by reported lifetime use

Eleven frequent users reported at least 100 marijuana exposures, while ten infrequent users reported ten or fewer. Participants received placebo and two oral THC doses in separate sessions, with subjective questionnaires over five hours. Those history definitions should not be silently replaced by current daily use.

The lower-dose finding differed from the higher-dose finding

At 7.5 mg, frequent users showed increased feel-drug ratings relative to placebo, while infrequent users did not. At 15 mg, frequent users reported lower feel-drug ratings than infrequent users, consistent with tolerance in that comparison. Infrequent users also reported greater sedation at the higher dose.

Subjective ratings are not a complete impairment measure

The findings show dose-dependent differences in reported experience. They do not establish a corresponding difference in driving ability or prove that a lower reported effect means preserved performance. Existing use history also carries possible group differences beyond pharmacological adaptation, so the comparison does not isolate one cause.

For interpreting oral THC, dose and the way use history was defined are both essential. A statement that experienced users always feel less would contradict the lower-dose result. The study supports a more conditional account without providing an individual exposure or impairment threshold.

Related: interpreting cannabis tolerance claims.

Research cited

Kirk JM; de Wit H. Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacology, biochemistry, and behavior (1999). doi:10.1016/s0091-3057(98)00264-0. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

What Skin Tags Along an Abrasion Can Show About Direction

Knight’s Forensic Pathology explains how superficial skin fragments can help interpret a scraping injury.

Spread the love

Read Article: What Skin Tags Along an Abrasion Can Show About Direction

Why Stomach Contents Provide an Uncertain Timeline After Death

Knight’s Forensic Pathology explains how meal composition and stress complicate estimates based on stomach contents.

Spread the love

Read Article: Why Stomach Contents Provide an Uncertain Timeline After Death

What Did the Confirmatory Phase 3 MDMA-Assisted Therapy Trial Add?

The MAPP2 trial replicated symptom and functional improvements in a more ethnoracially diverse PTSD sample. It also left important questions about blinding, long-term outcomes, exclusions, and sponsor involvement.

Spread the love

Read Article: What Did the Confirmatory Phase 3 MDMA-Assisted Therapy Trial Add?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us